Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department : a multicentre randomised clinical trial
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
BACKGROUND: Chest CT displays chest pathology better than chest X-ray (CXR). We evaluated the effects on health outcomes of replacing CXR by ultra-low-dose chest-CT (ULDCT) in the diagnostic work-up of patients suspected of non-traumatic pulmonary disease at the emergency department.
METHODS: Pragmatic, multicentre, non-inferiority randomised clinical trial in patients suspected of non-traumatic pulmonary disease at the emergency department. Between 31 January 2017 and 31 May 2018, every month, participating centres were randomly allocated to using ULDCT or CXR. Primary outcome was functional health at 28 days, measured by the Short Form (SF)-12 physical component summary scale score (PCS score), non-inferiority margin was set at 1 point. Secondary outcomes included hospital admission, hospital length of stay (LOS) and patients in follow-up because of incidental findings.
RESULTS: 2418 consecutive patients (ULDCT: 1208 and CXR: 1210) were included. Mean SF-12 PCS score at 28 days was 37.0 for ULDCT and 35.9 for CXR (difference 1.1; 95% lower CI: 0.003). After ULDCT, 638/1208 (52.7%) patients were admitted (median LOS of 4.8 days; IQR 2.1-8.8) compared with 659/1210 (54.5%) patients after CXR (median LOS 4.6 days; IQR 2.1-8.8). More ULDCT patients were in follow-up because of incidental findings: 26 (2.2%) versus 4 (0.3%).
CONCLUSIONS: Short-term functional health was comparable between ULDCT and CXR, as were hospital admissions and LOS, but more incidental findings were found in the ULDCT group. Our trial does not support routine use of ULDCT in the work-up of patients suspected of non-traumatic pulmonary disease at the emergency department.
TRIAL REGISTRATION NUMBER: NTR6163.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
|---|---|
| Enthalten in: |
Thorax - 78(2023), 5 vom: 10. Mai, Seite 515-522 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Emergency medicine |
|---|
| Anmerkungen: |
Date Completed 17.04.2023 Date Revised 24.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/thoraxjnl-2021-218337 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342103083 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342103083 | ||
| 003 | DE-627 | ||
| 005 | 20231226013320.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/thoraxjnl-2021-218337 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1140.xml |
| 035 | |a (DE-627)NLM342103083 | ||
| 035 | |a (NLM)35688623 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a van den Berk, Inge A H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department |b a multicentre randomised clinical trial |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.04.2023 | ||
| 500 | |a Date Revised 24.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a BACKGROUND: Chest CT displays chest pathology better than chest X-ray (CXR). We evaluated the effects on health outcomes of replacing CXR by ultra-low-dose chest-CT (ULDCT) in the diagnostic work-up of patients suspected of non-traumatic pulmonary disease at the emergency department | ||
| 520 | |a METHODS: Pragmatic, multicentre, non-inferiority randomised clinical trial in patients suspected of non-traumatic pulmonary disease at the emergency department. Between 31 January 2017 and 31 May 2018, every month, participating centres were randomly allocated to using ULDCT or CXR. Primary outcome was functional health at 28 days, measured by the Short Form (SF)-12 physical component summary scale score (PCS score), non-inferiority margin was set at 1 point. Secondary outcomes included hospital admission, hospital length of stay (LOS) and patients in follow-up because of incidental findings | ||
| 520 | |a RESULTS: 2418 consecutive patients (ULDCT: 1208 and CXR: 1210) were included. Mean SF-12 PCS score at 28 days was 37.0 for ULDCT and 35.9 for CXR (difference 1.1; 95% lower CI: 0.003). After ULDCT, 638/1208 (52.7%) patients were admitted (median LOS of 4.8 days; IQR 2.1-8.8) compared with 659/1210 (54.5%) patients after CXR (median LOS 4.6 days; IQR 2.1-8.8). More ULDCT patients were in follow-up because of incidental findings: 26 (2.2%) versus 4 (0.3%) | ||
| 520 | |a CONCLUSIONS: Short-term functional health was comparable between ULDCT and CXR, as were hospital admissions and LOS, but more incidental findings were found in the ULDCT group. Our trial does not support routine use of ULDCT in the work-up of patients suspected of non-traumatic pulmonary disease at the emergency department | ||
| 520 | |a TRIAL REGISTRATION NUMBER: NTR6163 | ||
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a emergency medicine | |
| 650 | 4 | |a imaging/CT MRI etc | |
| 650 | 4 | |a pneumonia | |
| 650 | 4 | |a respiratory infection | |
| 700 | 1 | |a Kanglie, Maadrika M N P |e verfasserin |4 aut | |
| 700 | 1 | |a van Engelen, Tjitske S R |e verfasserin |4 aut | |
| 700 | 1 | |a Altenburg, Josje |e verfasserin |4 aut | |
| 700 | 1 | |a Annema, Jouke T |e verfasserin |4 aut | |
| 700 | 1 | |a Beenen, Ludo F M |e verfasserin |4 aut | |
| 700 | 1 | |a Boerrigter, Bart |e verfasserin |4 aut | |
| 700 | 1 | |a Bomers, Marije K |e verfasserin |4 aut | |
| 700 | 1 | |a Bresser, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Eryigit, Elvin |e verfasserin |4 aut | |
| 700 | 1 | |a Groenink, Maarten |e verfasserin |4 aut | |
| 700 | 1 | |a Hochheimer, Suzanne M R |e verfasserin |4 aut | |
| 700 | 1 | |a Holleman, Frits |e verfasserin |4 aut | |
| 700 | 1 | |a Kooter, Jos A J |e verfasserin |4 aut | |
| 700 | 1 | |a van Loon, Ramon B |e verfasserin |4 aut | |
| 700 | 1 | |a Keijzers, Mitran |e verfasserin |4 aut | |
| 700 | 1 | |a van der Lee, Ivo |e verfasserin |4 aut | |
| 700 | 1 | |a Luijendijk, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Meijboom, Lilian J |e verfasserin |4 aut | |
| 700 | 1 | |a Middeldorp, Saskia |e verfasserin |4 aut | |
| 700 | 1 | |a Schijf, Laura J |e verfasserin |4 aut | |
| 700 | 1 | |a Soetekouw, Robin |e verfasserin |4 aut | |
| 700 | 1 | |a Sprengers, Ralf W |e verfasserin |4 aut | |
| 700 | 1 | |a Montauban van Swijndregt, Alexander D |e verfasserin |4 aut | |
| 700 | 1 | |a de Monyé, Wouter |e verfasserin |4 aut | |
| 700 | 1 | |a Ridderikhof, Milan L |e verfasserin |4 aut | |
| 700 | 1 | |a Winter, Michiel M |e verfasserin |4 aut | |
| 700 | 1 | |a Bipat, Shandra |e verfasserin |4 aut | |
| 700 | 1 | |a Dijkgraaf, Marcel G W |e verfasserin |4 aut | |
| 700 | 1 | |a Bossuyt, Patrick M M |e verfasserin |4 aut | |
| 700 | 1 | |a Prins, Jan M |e verfasserin |4 aut | |
| 700 | 1 | |a Stoker, Jaap |e verfasserin |4 aut | |
| 700 | 0 | |a OPTIMACT study group |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Thorax |d 1946 |g 78(2023), 5 vom: 10. Mai, Seite 515-522 |w (DE-627)NLM00010387X |x 1468-3296 |7 nnns |
| 773 | 1 | 8 | |g volume:78 |g year:2023 |g number:5 |g day:10 |g month:05 |g pages:515-522 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/thoraxjnl-2021-218337 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 78 |j 2023 |e 5 |b 10 |c 05 |h 515-522 | ||